0001209191-18-006131.txt : 20180131
0001209191-18-006131.hdr.sgml : 20180131
20180131083940
ACCESSION NUMBER: 0001209191-18-006131
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180123
FILED AS OF DATE: 20180131
DATE AS OF CHANGE: 20180131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celgene Alpine Investment Co., LLC
CENTRAL INDEX KEY: 0001581774
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 18561092
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: X1
ZIP: 07901
BUSINESS PHONE: 908-673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: X1
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celgene Switzerland LLC
CENTRAL INDEX KEY: 0001661486
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 18561093
BUSINESS ADDRESS:
STREET 1: AON HOUSE
STREET 2: 30 WOODBOURNE AVENUE
CITY: PEMBROKE
STATE: D0
ZIP: HM 08
BUSINESS PHONE: 4412964803
MAIL ADDRESS:
STREET 1: AON HOUSE
STREET 2: 30 WOODBOURNE AVENUE
CITY: PEMBROKE
STATE: D0
ZIP: HM 08
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celgene European Investment Co LLC
CENTRAL INDEX KEY: 0001577650
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 18561091
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: 908-673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 18561094
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2018-01-23
2018-01-23
0
0001439222
AGIOS PHARMACEUTICALS INC
AGIO
0000816284
CELGENE CORP /DE/
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
0
1
0
0001661486
Celgene Switzerland LLC
AON HOUSE
30 WOODBOURNE AVENUE
PEMBROKE
D0
HM 08
BERMUDA
0
0
1
0
0001581774
Celgene Alpine Investment Co., LLC
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
0
1
0
0001577650
Celgene European Investment Co LLC
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
0
1
0
Common Stock
2018-01-23
4
P
0
851154
67.00
A
1374599
D
Common Stock
5343834
I
See footnote
This Form 4 Amendment is being submitted to correct the date of earliest transaction in box 3 to reflect January 23, 2018.
Of these shares, 624,575 shares are owned directly by Celgene Switzerland LLC, 708,333 shares are owned directly by Celgene Alpine Investment Co. LLC, and 4,010,926 shares are owned directly by Celgene European Investment Company LLC, each a wholly-owned subsidiary of Celgene Corporation ("Celgene"), and Celgene has the power to vote, acquire, hold and dispose of all such shares. Celgene disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
/s/Peter N. Kellogg, Executive Vice President and Chief Financial Officer,
Celgene Corporation
2018-01-25
/s/ Kevin Mello, Manager, Celgene Switzerland LLC
2018-01-25
/s/ Kevin Mello, Manager, Celgene Alpine Investment Co., LLC
2018-01-25
/s/ Kevin Mello, Manager, Celgene European Investment Co., LLC
2018-01-25